- Home
- FGI vs ONCO Comparison
FGI vs ONCO Comparison
Compare FGI & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- ONCO
- Stock Information
- Founded
- FGI 1987
- ONCO 2018
- Country
- FGI United States
- ONCO United States
- Employees
- FGI N/A
- ONCO N/A
- Industry
- FGI Industrial Specialties
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- ONCO Health Care
- Exchange
- FGI Nasdaq
- ONCO Nasdaq
- Market Cap
- FGI 7.9M
- ONCO 1.8M
- IPO Year
- FGI 2022
- ONCO 2022
- Fundamental
- Price
- FGI $8.56
- ONCO $3.16
- Analyst Decision
- FGI
- ONCO
- Analyst Count
- FGI 0
- ONCO 0
- Target Price
- FGI N/A
- ONCO N/A
- AVG Volume (30 Days)
- FGI 2.1M
- ONCO 45.9K
- Earning Date
- FGI 11-10-2025
- ONCO 08-14-2025
- Dividend Yield
- FGI N/A
- ONCO N/A
- EPS Growth
- FGI N/A
- ONCO N/A
- EPS
- FGI N/A
- ONCO N/A
- Revenue
- FGI $135,904,413.00
- ONCO $1,326,959.00
- Revenue This Year
- FGI $5.57
- ONCO N/A
- Revenue Next Year
- FGI $8.02
- ONCO N/A
- P/E Ratio
- FGI N/A
- ONCO N/A
- Revenue Growth
- FGI 12.30
- ONCO N/A
- 52 Week Low
- FGI $2.28
- ONCO $2.61
- 52 Week High
- FGI $12.62
- ONCO $552.50
- Technical
- Relative Strength Index (RSI)
- FGI 77.50
- ONCO 52.40
- Support Level
- FGI $3.88
- ONCO $3.00
- Resistance Level
- FGI $12.62
- ONCO $3.32
- Average True Range (ATR)
- FGI 0.64
- ONCO 0.16
- MACD
- FGI 0.48
- ONCO 0.08
- Stochastic Oscillator
- FGI 55.09
- ONCO 75.74
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.